-       Report 
   - November 2025
    -  180 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                -       Report 
   - July 2025
    -  350 Pages 
    Global
   
   From       €4441EUR$4,949USD£3,898GBP 
                  -       Report 
   - May 2025
    -  120 Pages 
    Global
   
   From       €3699EUR$4,123USD£3,247GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - November 2025
    -  481 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                -       Report 
   - May 2024
    -  70 Pages 
    United States
   
   From       €3544EUR$3,950USD£3,111GBP 
                 -       Report 
   - January 2024
    -  100 Pages 
    Global
   
   From       €5339EUR$5,950USD£4,686GBP 
                -       Report 
   - August 2025
    -  85 Pages 
    United Kingdom
   
   From       €3141EUR$3,500USD£2,756GBP 
                -       Report 
   - July 2024
    -  120 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                  -       Report 
   - October 2023
    -  146 Pages 
    Global
   
   From       €3165EUR$3,528USD£2,778GBP 
      €3724EUR$4,150USD£3,268GBP 
                      Hemodialysis Vascular Grafts are medical devices used in the treatment of end-stage renal disease (ESRD). They are used to create a connection between the patient's artery and vein, allowing for the efficient exchange of blood during hemodialysis. The grafts are typically made of synthetic materials such as polytetrafluoroethylene (PTFE) or polyurethane, and are designed to be durable and resistant to infection. The global market for Hemodialysis Vascular Grafts is driven by the increasing    prevalence of ESRD, as well as the growing demand for minimally invasive treatments.
The market is highly competitive, with a number of major players such as Medtronic, Baxter, B. Braun, and Terumo Corporation. Other prominent vendors include AngioDynamics, Cook Medical, and Merit Medical Systems. Show Less   Read more